Viral myocarditis: Balance between viral infection and immune response

Canadian Journal of Cardiology

Volumn 12, Issue 10, 1996, Pages 935-943

  Liu, Peter ^a,b   Martino, Tami ^a   Opavsky, Mary Ann ^a   Penninger, Josef ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Dilated cardiomyopathy; Viral myocarditis

Indexed keywords

AMLODIPINE; ANTIVIRUS AGENT; AZATHIOPRINE; CARVEDILOL; CYCLOSPORIN; CYTOKINE; STEROID;

ACUTE HEART FAILURE; CLINICAL PRACTICE; EARLY DIAGNOSIS; GENE THERAPY; HEART BLOOD VESSEL; HEART DILATATION; HEART MUSCLE BIOPSY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MOLECULAR BIOLOGY; MORTALITY; NORTH AMERICA; PERSISTENT VIRUS INFECTION; PROGNOSIS; REVIEW; VIRUS INFECTION; VIRUS MYOCARDITIS;

HUMANS; MYOCARDITIS; VIRUS DISEASES;

EID: 0029797631     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Jin O, Sole MJ, Butany JW, et al. The detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by the polymerase chain reaction. Circulation 1990;82:8-16.
2. Parrillo JE, Aretz HT, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 1984;69:93-101.
3. Hosenpud JD, McAnulty JH, Niles NR. Unexpected myocardial disease in patients with life threatening arrhythmias. Br Heart J 1986;56:55-61.
4. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-44.
5. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994;90:330-9.
6. Anderson DW, Virmani R, Reilly JM, et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 1988;11:792-9.
7. Herskowitz A, Vlahov D, Willoughby S, et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993;71:955-8.
8. Hagar JM, Rahimtoola SH. Chagas' heart disease in the United States. N Engl J Med 1991;325:763-8.
9. Andersson B, Caidahl K, Waagstein F. Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J 1995;16:53-60.
10. Lilienfeld DE, Sprafka JM, Pham DL, Baxter J. Morbidity from congestive and hypertrophic cardiomyopathy in the Minneapolis- St. Paul metropolitan area: 1979-1984. Cardiology 1992;80:71-6.
11. Gore I, Saphir O. Myocarditis: a classification of 1,402 cases. Am Heart J 1947;38:827.
12. Mason JW, O'Connell JR, Herskowitz A, et al, Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
13. Ah H, Yang L, McLaughlin PR, Butany J, Liu P. Factors predicting outcome in myocarditis/dilated cardiomyopathy. Can J Cardiol 1994;10(Suppl C):73C. (Abst)
14. Liu P, Wang E, Sole M. Pathology and pathogenesis of myocarditis: A 1990's perspective Cardiovasc Pathol 1993;2.247-57.
15. Martino T, Liu P, Sole MJ. Viral infection and the pathogenesis of myocarditis and dilated cardiomyopathy. Circ Res 1994;74:182-8.
16. Sole MJ, Liu P. Viral myocarditis: developing a paradigm for pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993;22(Suppl 4A):99-105.
17. Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992;89:314-8.
18. Wee L, Liu P, Penn L, et al. Persistence of viral genome into late stages of murine myocarditis detected by polymerase chain reaction- Circulation 1992;86:1605-14.
19. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW. Coxackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol 1987;9:1311-9.
20. Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. N Engl J Med 1994;330:1129-35.
21. Beck MA, Shi Q, Morris VC, Levander OA Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med 1995;1:405-6.
22. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 1985;82:4818-22.
23. Chow LH, Beisel KW, McManus BM. Enteroviral infection of mice with severe combined immunodeficiency, evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992;66:24-31.
24. Schnurr DP, Cao Y, Schmidt NJ. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice. J Gen Virol 1984;65:1197-201.
25. Cronin ME, Lov LA, Miller FW, McClintock PR, Plotz PH. The natural history of EMC virus-induced myositis and myocarditis in mice: virus persistence demonstrated by in situ hybridization. J Exp Med 1988;168:1639-48.
26. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 1992;86 522-30
27. Why HJ, Meanv BT, Richardson PJ, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994;89:2582-9.
28. Chow LH, Gauntt CJ, McManus BM. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice: a pathologic characterization of heart tissue damage. Lab Invest 1991;64:55-64.
29. Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation 1988;77:645-53.
30. Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994;263:1612-5.
31. Aitken K, Penninger J, Mak T, et al. Increased susceptibility to coxsackieviral myocarditis in IRF-1 transgenic knockout mice. Circulation 1994;90:1139.
32. Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 1994;89:2836-42.
33. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant BIO. A mice. J Exp Med 1992;175:1123-9.
34. Huber SA, Polgar J, Schultheiss P, Schwimmbeck P. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 1994;68:195-206.
35. Martino T, Aitken K, Penninger J, et al. Mice lacking p56lck are resistant to coxsackievirus B3 induced heart disease. J Cell Biochem 1995;19:283A.
36. Molina TJ, Bachmann MF, Kundig TM, Zinkernagel RM, Mak TW. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions. J Immunol 1993;151:699-706.
37. Penninger JM, Neu N, Timms E, et al. Induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J Exp Med 1993;178:1837-42.
38. Godeny EK, Gauntt CJ. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 1986;137:1695-702.
39. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995;269:1583-5.
40. Schulze K, Becker B, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 1989;64:179-92.
41. Schwimmbeck PL, Badorff C, Schultheiss HP, Strauer BE. Transfer of human myocarditis into severe combined immunodeficiency mice. Circ Res 1994;75:156-64.
42. Caforio ALP, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
43. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6.
44. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta- adrenergic responsiveness. Proc Natl Acad Sci USA 1989;86:6753-7.
45. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy, but not in ischaemic or valvar heart disease. Br Heart J 1995;74:426-30.
46. Herskowitz A, Ahmed-Ansari A, Neumann DA, et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a non-histologic marker of myocarditis. J Am Coll Cardiol 1990;15:624-32.
47. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 1991;83:1866-72.
48. Dong R, Liu P, Wee L, Butany J, Sole M. Verapamil attenuates the histological features of murine myocarditis. J Clin Invest 1992;90:2022-30.
49. Pandey AS, Sole MJ, Floras JS, et al The role of sympathetic activity in murine myocarditis leading to dilated cardiomyopathy. J Am Coll Cardiol 1995;25:132A.
50. Tominaga M, Matsumori A, Okada I, Yamada T, Kawai C. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. Circulation 1991;83:2021-8.
51. Rezkalla S, Kloner RA, Khatib G, Khatib R. Beneficial effects of captopril in acute Coxasackievirus B3 murine myocarditis. Circulation 1990;81:1039-46.
52. Koide H, Kitaura Y, Ukimura A, Kawamura K, Hirai K. Genomic detection of enteroviruses in the myocardium - studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 1992;56:1081-93.
53. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis, a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
54. Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
55. Obrader D, Ballester M, Carrio I, et al. Active myocardial damage without attending inflammatory response in dilated cardiomyopathy. J Am Coll Cardiol 1993;21:1667-71.
56. Dec GW, Fallon JT, Southern JF, Palacios I. Borderline myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol 1990;15:283-9.
57. Dec GW, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates and clinical outcome. N Engl J Med 1985;312:885-90.
58. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of Coxsakie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;i:1120-3.
59. Kandolf R, Ameis D, Kirschener P, Canu A, Hofschneider PH. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 1987;84:6272-6.
60. Martino T, Sole MJ, Penn L, Liew CC, Liu P. Quantitation of enteroviral RNA by competitive polymerase chain reaction. J Clin Microbiol 1993;31:2634-40.
61. El-Hagrassy MMO, Banatvala JE, Coltart DJ. Coxsakie B virus specific IgM response in patients with cardiac and other diseases. Lancet 1980;ii:1660-2.
62. Prabhakar BS, Haspel MV, McClintock PR, et al. High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 1982;300:374-6.
63. Tracy S, Chapman NM, McManus BM, Pallansch MA, Beck MA, Carstens J. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 1990;22:403-14.
64. O'Connell JB, Henkin RE, Robinson JA, Subramanian R, Scanlon RJ, Gunnar RM. Gallium-67 imaging and biopsy-proven myocarditis. Circulation 1984;70:58-62.
65. Yasuda T, Palacios IF, Dec GW, et al. Indium-111 monoclonal angimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987;76:306-11.
66. Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990;16:97-104.
67. Gatmaitan BG, Chason JL, Lerner AM. Augmentation of the virulence of murine coxsackievirus B-3 myocardiopathy by exercise. J Exp Med 1970;131:1121-36.
68. Metoprolol in Dilated Cardiomyopthy (MDC) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
69. Packer M, Bristow MR, Cohn JN, et al, US Carvedilol Heart Failure Study Group. The effect of carvediolol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
70. Packer M, O'Connor CM, Ghali JK, et al, PRAISE Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Journal? 1996;volume?:pages?
71. Frizelle S, Schwarz J, Huber SA, Leslie K. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am J Pathol 1992;141:203-9.
72. Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BF. Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. Am Heart J 1991;121:922-6.
73. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 1991;17:458-60.
74. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061-8.
75. Jones SR, Herskowitz A, Hutchins GM, Baughman KL. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 1991;68:370-6.
76. Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol 1985;6:797-801.
77. Keogh AM, Billingham MF, Schroeder JS. Rapid histological changes in endomyocardial biopsy specimens after myocarditis. Br Heart J 1990;64:406-8.
78. Kanda T, Yokoyama T, Iami S, Suzuki T, Murata K, Kobayashi I. Effect of combination therapy with OK432 and recombinant human interferon-alpha A/D on atrial natriuretic peptide gene expression in mice with viral myocarditis. J Pharmacol Exp Ther 1995;274:494-8.
79. Matsumori A, Crumpacker CS, Abelmarm WH. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model. J Am Coll Cardiol 1987;9:1320-5.
80. Figulla HR, Stille-Siegener M, Mall G, Heim A, Kreuzer H. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;25:1170-5.
81. Kishimoto C, Crumpacker CS, Abelmann WH. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analysis of lymphocyte subsets. J Am Coll Cardiol 1988;12:1334-41.
82. Keeling PJ, Jeffery S, Caforio AL, et al. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J 1992;68:554-9.
83. Grasso M, Arbustini E, Silini E, et al. Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 1992;69:658-64.
84. Kandolf R, Klingel K, Mertsching H, et al. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur Heart J 1991;12(Suppl D):49D-55D.
85. Tracy S, Wiegand V, McManus B, et al. Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J Am Coll Cardiol 1990;15:1688-94.